Justin Baptist, MD
Hospitalist · Atlantic City, NJNPI 1982095758
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,450 of the $22,887 with a category attached, or 89.4%. AbbVie accounts for 96.3% of it on its own, with 13 other manufacturers making up the rest. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $177.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Merck$173
- Insmed, Inc.$125
- Shionogi Inc$90
- Paratek Pharmaceuticals, Inc.$89
- Philips North America LLC$77
- plus $289 from 8 others
What the payments were for
- Speaking & faculty fees$20,45089%
- Food & beverage$2,42411%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $22,044 |
| Merck | 12 | $173 |
| Insmed, Inc. | 8 | $125 |
| Shionogi Inc | 5 | $90 |
| Paratek Pharmaceuticals, Inc. | 5 | $89 |
| Philips North America LLC | 4 | $77 |
| Viiv Healthcare Company | 4 | $68 |
| La Jolla Pharmaceutical Company | 3 | $60 |
| Cumberland Pharmaceuticals, Inc. | 4 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Melinta Therapeutics, LLC | 2 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Vyera Pharmaceuticals, LLC | 1 | $13 |
| Theratechnologies Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,887 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MicafunginMicafungin Sodium | 12 | $15,879 |
| ErtapenemErtapenem Sodium | 27 | $10,209 |
| Daptomycin | 37 | $6,042 |
| Fosfomycin Tromethamine | 14 | $4,530 |
| Sodium Chloride0.9 % Sodium Chloride | 48 | $1,839 |
| CeftriaxoneCeftriaxone Sodium | 28 | $1,027 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Atlantic City
- Mohamed BakrAtlantic City$8K
- Urmil PatelAtlantic City$2K
- Javid IqbalAtlantic City$2K
- Mary OnwukaAtlantic City$1K
- Mohammed UsmanToms River$33K
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Jason NehmadNeptune$7K
- Rebecca ZweiflerMorristown$6K
- Scott KaufmanMount Holly$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.